Therapeutic Area market research reports by DelveInsight

• Community-acquired pneumonia (CAP) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Community-acquired pneumonia (CAP) - Pipeline Insight, 2024 DelveInsight’s, “Community-acquired pneumonia (CAP) - Pipeline Insight, 2024” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Community-acquired pneumonia (CAP) pipeline landscape. It covers the pipeline ... Read More

• CAR T-Cell Therapy for Non-Hodgkin’s lymphoma– - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  CAR T-Cell Therapy for Non-Hodgkin’s lymphoma– - Pipeline Insight, 2024 DelveInsight’s, “CAR T-Cell Therapy for Non-Hodgkin’s Lymphoma - Pipeline Insight, 2024,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in CAR T-Cell Therapy for Non-Hodgkin’s Lymphoma pipeline ... Read More

• Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Insight, 2024 Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Overview ""Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insig ... Read More

• Single Ventricle Heart Disease - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Single Ventricle Heart Disease - Pipeline Insight, 2024 Single Ventricle Heart Disease Overview ""Single Ventricle Heart Disease Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Single Ventricle He ... Read More

• Hospital-Acquired & Ventilator-Associated Bacterial Pneumonia (HABP/VABP) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Hospital-Acquired & Ventilator-Associated Bacterial Pneumonia (HABP/VABP) - Pipeline Insight, 2024 Hospital-Acquired & Ventilator-Associated Bacterial Pneumonia (HABP/VABP) Overview ""Hospital-Acquired & Ventilator-Associated Bacterial Pneumonia (HABP/VABP) Pipeline Insight, 2024"" report by DelveIn ... Read More

• Uveitic Glaucoma - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Uveitic Glaucoma - Pipeline Insight, 2024 Uveitic Glaucoma Overview ""Uveitic Glaucoma Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Uveitic Glaucoma market. A detailed picture of the Uveitic Gl ... Read More

• Thymus Cancer - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Thymus Cancer - Pipeline Insight, 2024 Thymus Cancer Overview ""Thymus Cancer Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Thymus Cancer market. A detailed picture of the Thymus Cancer pipeline ... Read More

• Undifferentiated Pleomorphic Sarcoma (UPS) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Undifferentiated Pleomorphic Sarcoma (UPS) - Pipeline Insight, 2024 Undifferentiated Pleomorphic Sarcoma (UPS) Overview ""Undifferentiated Pleomorphic Sarcoma (UPS) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth pros ... Read More

• Traumatic Brain Injury(TBI) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Traumatic Brain Injury(TBI) - Pipeline Insight, 2024 Traumatic Brain Injury(TBI) Overview ""Traumatic Brain Injury(TBI) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Traumatic Brain Injury(TBI) ... Read More

• Postmenopausal Vaginal Atrophy - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Postmenopausal Vaginal Atrophy - Pipeline Insight, 2024 Postmenopausal Vaginal Atrophy Overview ""Postmenopausal Vaginal Atrophy Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Postmenopausal Vagi ... Read More

• Vulvovaginal Candidiasis - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Vulvovaginal Candidiasis - Pipeline Insight, 2024 DelveInsight’s, “Vulvovaginal Candidiasis - Pipeline Insight, 2024,” report provides comprehensive insights about 7+ companies and 7+ pipeline drugs in Vulvovaginal Candidiasis pipeline landscape. It covers the pipeline drug profiles, including clini ... Read More

• Therapy Resistant Psychiatric Disorders - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Therapy Resistant Psychiatric Disorders - Pipeline Insight, 2024 Therapy Resistant Psychiatric Disorders Overview ""Therapy Resistant Psychiatric Disorders Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects acr ... Read More

• Urinary Incontinence - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Urinary Incontinence - Pipeline Insight, 2024 Urinary Incontinence Overview ""Urinary Incontinence Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Urinary Incontinence market. A detailed picture o ... Read More

• Fuchs Endothelial Corneal Dystrophy (FECD) - Epidemiology Forecast - 2034

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 3,950

  Fuchs Endothelial Corneal Dystrophy (FECD) - Epidemiology Forecast - 2034 Key Highlights DelveInsight’s analyst projects that the Total Diagnosed Prevalent Cases of Fuchs Endothelial Corneal Dystrophy (FECD) in the 7MM were ~18.9 million in 2022 and these cases are going to increase during the forec ... Read More

• Acute Lung Injury - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Acute Lung Injury - Pipeline Insight, 2024 Acute Lung Injury Overview ""Acute Lung Injury Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Acute Lung Injury market. A detailed picture of the Acute ... Read More

• Acute Myelogenous Leukemia (AML) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Acute Myelogenous Leukemia (AML) - Pipeline Insight, 2024 Acute Myelogenous Leukemia (AML) Overview ""Acute Myelogenous Leukemia (AML) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Acute Myeloge ... Read More

• Juvenile Rheumatoid Arthritis - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Juvenile Rheumatoid Arthritis - Pipeline Insight, 2024 DelveInsight’s, “Juvenile Rheumatoid Arthritis – Pipeline Insight, 2024,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Juvenile Rheumatoid Arthritis pipeline landscape. It covers the pipeline drug profiles ... Read More

• Advanced Cancer Pain Management (ACPM) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Advanced Cancer Pain Management (ACPM) - Pipeline Insight, 2024 Advanced Cancer Pain Management (ACPM) Overview ""Advanced Cancer Pain Management (ACPM) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across ... Read More

• Rheumatoid Arthritis - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 3,000

  Rheumatoid Arthritis - Pipeline Insight, 2024 DelveInsight’s, “Rheumatoid Arthritis - Pipeline Insight, 2024” report provides comprehensive insights about 95+ companies and 100+ pipeline drugs in Rheumatoid Arthritis pipeline landscape. It covers the pipeline drug profiles, including clinical and n ... Read More

• Chronic Ocular Pain - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Chronic Ocular Pain - Pipeline Insight, 2024 Chronic Ocular Pain Overview ""Chronic Ocular Pain Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Chronic Ocular Pain market. A detailed picture of th ... Read More

• Endometriosis Pain - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Endometriosis Pain - Pipeline Insight, 2024 Endometriosis Pain Overview ""Endometriosis Pain Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Endometriosis Pain market. A detailed picture of the En ... Read More

• Androgenetic Alopecia - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Androgenetic Alopecia - Pipeline Insight, 2024 DelveInsight’s, “Androgenetic Alopecia – Pipeline Insight, 2024,” report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Androgenetic Alopecia pipeline landscape. It covers the pipeline drug profiles, including clinical and ... Read More

• Anaplastic Thyroid Cancer - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Anaplastic Thyroid Cancer - Pipeline Insight, 2024 DelveInsight’s, “Anaplastic Thyroid Cancer - Pipeline Insight, 2024,” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Anaplastic Thyroid Cancer pipeline landscape. It covers the pipeline drug profiles, including cl ... Read More

• Fuchs Endothelial Corneal Dystrophy (FECD) - Market Insight, Epidemiology And Market Forecast - 2034

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Fuchs Endothelial Corneal Dystrophy (FECD) - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The prevalent cases of schizophrenia are projected to increase during the forecast period (2023–2034) due to the rising awareness regarding mental illness and improvements in diagnosis ... Read More

• Age Related Macular Degeneration - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Age Related Macular Degeneration - Pipeline Insight, 2024 Age Related Macular Degeneration Overview ""Age Related Macular Degeneration Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Age Related M ... Read More

< prev 17 18 19 20 21 22 23 24 25 26 next >